BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling - PubMed (original) (raw)
BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling
Sarah L Rowland et al. J Immunol. 2010.
Abstract
BAFF is an important prosurvival cytokine for mature B cells. However, previous studies have shown that BAFFR is already expressed at the immature B cell stage, and that the prosurvival protein Bcl-2 does not completely complement the B cell defects resulting from the absence of BAFFR or BAFF. Thus, we hypothesized that BAFF also functions to aid the differentiation of nonautoreactive immature B cells into transitional B cells and to promote their positive selection. We found that BAFFR is expressed at higher levels on nonautoreactive than on autoreactive immature B cells and that its expression correlates with that of surface IgM and with tonic BCR signaling. Our data indicate that BAFFR signaling enhances the generation of transitional CD23(-) B cells in vitro by increasing cell survival. In vivo, however, BAFFR signaling is dispensable for the generation of CD23(-) transitional B cells in the bone marrow, but it is important for the development of transitional CD23(-) T1 B cells in the spleen. Additionally, we show that BAFF is essential for the differentiation of CD23(-) into CD23(+) transitional B cells both in vitro and in vivo through a mechanism distinct from that mediating cell survival, but requiring tonic BCR signaling. In summary, our data indicate that BAFFR and tonic BCR signals cooperate to enable nonautoreactive immature B cells to differentiate into transitional B cells and to be positively selected into the naive B cell repertoire.
Figures
Figure 1. BAFF-R is differentially expressed by non-autoreactive and autoreactive immature B cells
(A) Bone marrow cells from non-autoreactive 3-83Igi, H-2d (non-aut) and autoreactive 3-83Igi, Rag1−/−, H-2b (aut) mice were analyzed by flow cytometry for expression of B220, IgD and BAFF-R. Dot plots show expression of B220 and IgD on live lymphoid cells. Histograms display BAFF-R levels on gated B220+IgD− cells (representing mostly immature B cells) from 3-83Igi, H-2d (non-aut, intact line) and 3-83Igi, Rag1−/−, H-2b (aut, dashed line) mice, and on B220− non-B cells (filled histogram). Data are representative of three mice per group analyzed in three independent experiments. (B) Bone marrow B220+IgD−CD23−CD43− immature B cells from two groups each of non-autoreactive 3-83Igi, H-2d (black bar) and autoreactive 3-83Igi, Rag1−/−, H-2b (gray bar) mice were sorted via Moflo to >95% purity and subjected to whole genome microarray analyses. The relative tnfrsf13c mRNA levels (arithmetic mean of normalized processed signals from two groups of mice) in the immature B cell samples are shown. Differences between the signals had P values <10−12.
Figure 2. Expression of BAFF-R correlates with that of surface IgM and tonic BCR signaling
(A) Flow cytometric analysis of IgM (top) and BAFF-R (bottom) expression on B220+IgD− bone marrow immature B cells that carry two types of non-autoreactive BCRs (B1-8/3-83Igi, H-2d mice, dual-non-aut, black intact line) or autoreactive and non-autoreactive BCRs (B1-8/3-83Igi, H-2b mice, dual-aut, black dashed line). Expression on B220− non-B cells (non-B, filled histograms) is shown as a negative control. Expression of BAFF-R on spleen CD19+ B cells from B1-8/3-83Igi, H-2d mice (dual-non-aut, SP, gray line) is shown as reference (spleen B cells from BALB/c mice had identical levels; data not shown). Data are representative of three mice per group collected in three independent experiments. (B) Flow cytometric analysis of IgM (top) and BAFF-R (bottom) expression on B220+IgD− bone marrow immature B cells that express normal levels (3-83Igi, H-2d mice, Normal, intact line) or low levels (3-83Igi-low mice, Low, dashed line) of non-autoreactive BCRs. Expression on B220− non-B cells (non-B, filled histograms) is shown as a negative control. Data are representative of four mice per group collected in three independent experiments. (C) Representative flow cytometric analysis of BAFF-R expression on immature B cells generated in culture with IL-7 and then transduced or not. Shown are BAFF-R levels on BCR-normal non-transduced cells from 3-83Igi, H-2d mice (Normal, filled histogram), and on BCR-low GFP control transduced (Low+GFP, dotted line) and N-RasD12 transduced (Low+RasD12, black line) cells from 3-83Igi-low mice. Immature B cells were gated as B220+IgD− (Normal) or B220+IgD−GFP+ (Low+GFP and Low+RasD12). (D) Geometric mean fluorescence intensity (MFI, ± SD, n = 4, from 4 independent experiments) of BAFF-R expression on immature B cells analyzed as described in (C). _P_-values of <0.05 (*) and <0.005 (**) are indicated. N.S. = not significant.
Figure 3. BAFF augments the differentiation of immature B cells into transitional B cells in vitro
(A) Schematic of the system to study the differentiation of immature B cells in vitro. Briefly, bone marrow cells are cultured with IL-7 for 3–4 days and then transferred in cultures with or without BAFF for two days. (B) Representative flow cytometric analysis of CD21, CD23 (dot plots) and IgD (histograms) expression on 3-83Igi, H-2d non-autoreactive immature B cells that express normal levels of BCR, at the beginning (day 0) and end (day 2) of culture with or without BAFF. Cells from 3-83Igi-mb1−/− mice were used as a negative control as the B cell population of these mice contains only pro-B cells and is deficient of immature B cells. Numbers represent frequencies of live B220+ B cells in indicated gates. Frequencies in histograms are shown only for 3-83Igi, H-2d cells. (C) Mean frequency (± SD, n = 11 mice from 11 independent experiments) of CD21+CD23− (T1-like), CD21+CD23+ (T2-like), and IgD+ (T1-like and T2-like) B cells at days 0 and 2 of culture with or without BAFF as described in (B). (D) Absolute cell numbers (± SD, n = 5 mice from 2 independent experiments) of CD21−CD23− (immature), CD21+CD23− (T1-like), and CD21+CD23+ (T2-like) B cells as described in (B). _P_-values of <0.05 (*), <0.005 (**), and <0.001 (***) are indicated. N.S. = not significant.
Figure 4. BAFF is required for the differentiation of CD23− into CD23+ transitional B cells via a mechanism distinct from that mediating cell survival
(A) Representative flow cytometric analysis of CD21 and CD23 expression on Thy1.1 control and Bcl-2 transduced non-autoreactive BCR-normal immature B cells from 3-83Igi, H-2d mice, at the beginning (day 0) and end (day 2) of culture with or without BAFF. Numbers represent frequencies of live B220+Thy1.1+ B cells in indicated gates. (B) Mean frequency (± SD, n = 2 pooled mice in each of 4 independent experiments) of CD21+CD23− (T1-like) and CD21+CD23+ (T2-like) transitional B cells in the transduced Thy1.1+ population of Thy1.1 control (black bars) and Bcl-2 (white bars) 3-83Igi, H-2d B cells at day 2 of culture with or without BAFF, as described in (A). _P_-values of <0.05 (*) are indicated. N.S. = not significant.
Figure 5. Increased levels of active N-Ras, but not of BAFF-R expression, rescue the differentiation of BCR-low immature B cells
(A) Representative flow cytometric analysis of BAFF-R expression on BCR-low immature B cells from 3-83Igi-low mice generated in cultures with IL-7 and transduced with either GFP only control (filled histogram) or BAFF-R (black line). Immature B cells were gated as live B220+IgD−GFP+. (B) Representative flow cytometric analysis of CD21 and CD23 expression on GFP control or BAFF-R transduced 3-83Igi-low B cells before (day 0) and after (day 2) culture with BAFF. Numbers represent frequencies of live B220+GFP+ B cells in indicated gates. (C) Mean frequency (± SD, n = 2 pooled mice in each of 3 independent experiments) of CD21+CD23− (T1-like) and CD21+CD23+ (T2-like) transitional B cells in GFP control (white bars) or BAFF-R (black bars) transduced (GFP+) 3-83Igi-low B cell populations at days 0 and 2 of culture with BAFF, as described in (B). (D) Representative flow cytometric analysis of CD21 and CD23 expression on GFP control or N-RasD12 transduced 3-83Igi-low B cells before (day 0) and after (day 2) culture with or without BAFF. Numbers represent frequencies of live B220+GFP+ B cells in indicated gates. (E) Mean frequency (± SD, n = 2 pooled mice in each of 7 independent experiments) of CD21+CD23− (T1-like) and CD21+CD23+ (T2-like) transitional B cells in GFP control (white bars) or N-RasD12 (black bars) transduced (GFP+) 3-83Igi-low B cell populations at days 0 and 2 of culture with BAFF, as described in (D). _P_-values of <0.05 (*) and <0.005 (**) are indicated. N.S. = not significant.
Figure 6. BAFF is required for optimal differentiation of wild-type T1, as well as T2, splenic transitional B cells
(A) Schematic for the generation of BAFF-R-deficient and -sufficient mixed bone marrow chimeras. Bone marrow cells from Ly5.1 and Ly5.2 congenic mice were used for these experiments. (B) B cells from mixed bone marrow chimeras generated as described in (A) were analyzed by flow cytometry for expression of the congenic marker Ly5.2. The bar graphs represent the mean frequencies (± SD, n = 6 chimera mice) of Ly5.2+ cells (BAFF-R+/+, black bars; BAFF-R−/−, white bars) in B cell populations from bone marrow and spleen tissues analyzed ex-vivo. Similar results were obtained in an additional independent experiment with three mice per group (data not shown). The following surface markers were used to discriminate B cell subsets within the total B220+ cell population in bone marrow: pro-B: IgM−CD43+; pre-B: IgM−CD2+; immature: IgM+IgD−; transitional T1-like: IgMhighIgDlowCD23−; transitional T2-like: IgMhighIgDlowCD23+; and in spleen: immature + transitional T1: CD24highCD23−; transitional T2+T3: CD24highCD23+; follicular (Fo.): CD24lowCD23+. The gating strategy used in the analysis is depicted in Figure S5A. _P_-values of <0.05 (*), <0.005 (**), and <0.001 (***) are indicated. N.S. = not significant.
Figure 7. IL-7 neither promotes nor blocks the differentiation of immature B cells into transitional B cells in vitro
(A) Bone marrow cells from 3-83Igi, H-2d mice were cultured in the presence of IL-7 for 3 days to generate BCR-normal non-autoreactive immature B cells. Immature B cells were then washed with PBS and re-cultured with or without BAFF or IL-7, as indicated. Dot plots are representative flow cytometric analyses of CD21 and CD23 expression on B cells at the beginning (day 0) and end (day 2) of culture with the indicated cytokines. Numbers represent frequencies of live B220+ B cells in indicated gates. IL-7 was used approximately at 250 pg/ml (low IL-7) and 10 ng/ml (high IL-7). (B) Immature B cells from 3-83Igi, H-2d mice were generated in the presence of IL-7 as described in (A) and then re-cultured in the presence of IL-7 and BAFF, as indicated. Cells were analyzed as described in (A). (C) Mean frequency (± SD, n = 3 mice, one in each of 3 independent experiments) of CD21+CD23− (T1-like) and CD21+CD23+ (T2-like) 3-83Igi, H-2d transitional B cells at days 0 and 2 of culture with indicated cytokines, as described in (A) and (B). (D) Absolute cell numbers (± SD, n = 3 mice from 1 experiment) of CD21−CD23− (immature), CD21+CD23− (T1-like), and CD21+CD23+ (T2-like) B cells at days 0 and 2 of culture with indicated cytokines as described in (A) and (B). _P_-values of <0.05 (*), <0.005 (**), and <0.001 (***) are indicated. N.S. = not significant.
Similar articles
- The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.
Schweighoffer E, Vanes L, Nys J, Cantrell D, McCleary S, Smithers N, Tybulewicz VL. Schweighoffer E, et al. Immunity. 2013 Mar 21;38(3):475-88. doi: 10.1016/j.immuni.2012.11.015. Epub 2013 Feb 28. Immunity. 2013. PMID: 23453634 Free PMC article. - Critical requirement for BCR, BAFF, and BAFFR in memory B cell survival.
Müller-Winkler J, Mitter R, Rappe JCF, Vanes L, Schweighoffer E, Mohammadi H, Wack A, Tybulewicz VLJ. Müller-Winkler J, et al. J Exp Med. 2021 Feb 1;218(2):e20191393. doi: 10.1084/jem.20191393. J Exp Med. 2021. PMID: 33119032 Free PMC article. - TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
Hayashi EA, Granato A, Paiva LS, Bertho AL, Bellio M, Nobrega A. Hayashi EA, et al. J Immunol. 2010 May 1;184(9):4662-72. doi: 10.4049/jimmunol.0903253. Epub 2010 Mar 31. J Immunol. 2010. PMID: 20357250 - Signalling crosstalk in B cells: managing worth and need.
Cancro MP. Cancro MP. Nat Rev Immunol. 2009 Sep;9(9):657-61. doi: 10.1038/nri2621. Nat Rev Immunol. 2009. PMID: 19704418 Free PMC article. Review. - BAFF and BAFF-Receptor in B Cell Selection and Survival.
Smulski CR, Eibel H. Smulski CR, et al. Front Immunol. 2018 Oct 8;9:2285. doi: 10.3389/fimmu.2018.02285. eCollection 2018. Front Immunol. 2018. PMID: 30349534 Free PMC article. Review.
Cited by
- Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
Eslami M, Schuepbach-Mallepell S, Diana D, Willen L, Kowalczyk-Quintas C, Desponds C, Peter B, Vigolo M, Renevey F, Donzé O, Luther SA, Yalkinoglu Ö, Alouche N, Schneider P. Eslami M, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2404309121. doi: 10.1073/pnas.2404309121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990948 - Hormones and B-cell development in health and autoimmunity.
Santana-Sánchez P, Vaquero-García R, Legorreta-Haquet MV, Chávez-Sánchez L, Chávez-Rueda AK. Santana-Sánchez P, et al. Front Immunol. 2024 Apr 12;15:1385501. doi: 10.3389/fimmu.2024.1385501. eCollection 2024. Front Immunol. 2024. PMID: 38680484 Free PMC article. Review. - B cell development and antibody responses in human immune system mice: current status and future perspective.
Zhang T, Liu W, Yang YG. Zhang T, et al. Sci China Life Sci. 2024 Apr;67(4):645-652. doi: 10.1007/s11427-023-2462-8. Epub 2024 Jan 15. Sci China Life Sci. 2024. PMID: 38270770 Review. - Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice.
Jackman RP, Darst O, Gaillard B, Tran JQ, Tomayko MM, Muench MO. Jackman RP, et al. Front Immunol. 2023 Nov 27;14:1281123. doi: 10.3389/fimmu.2023.1281123. eCollection 2023. Front Immunol. 2023. PMID: 38090570 Free PMC article. - Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
Luo Y, Qie Y, Gadd ME, Manna A, Rivera-Valentin R, To T, Li S, Yassine F, Murthy HS, Dronca R, Kharfan-Dabaja MA, Qin H. Luo Y, et al. Cancer Immunol Immunother. 2023 Dec;72(12):4031-4047. doi: 10.1007/s00262-023-03537-w. Epub 2023 Oct 10. Cancer Immunol Immunother. 2023. PMID: 37814001 Free PMC article.
References
- Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260–263. - PubMed
- Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194:1691–1697. - PMC - PubMed
- Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MacKay F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qian F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J, Ambrose C. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med. 2000;192:129–135. - PMC - PubMed
- Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15:289–302. - PubMed
- Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293:2111–2114. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AI022295/AI/NIAID NIH HHS/United States
- P30 CA046934/CA/NCI NIH HHS/United States
- R01 AI052157/AI/NIAID NIH HHS/United States
- R01 AI052310/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases